This study is testing whether regular injections of an experimental drug called OPT101 can help preserve the body's own insulin production in adults recently diagnosed with type 1 diabetes. Researchers will give the drug to 72 participants for up to one year to see if it's safe a…
Phase: PHASE2 • Sponsor: Op-T LLC • Aim: Disease control
Last updated Apr 02, 2026 05:42 UTC